Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

A Phase 1a/b Dose Escalation Study of Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS

Stephen B Howell, MD, Hongying Zhang, MD PhD, William G Rice, PhD

Blood (2019) 134 (Supplement_1): 5148.

https://doi.org/10.1182/blood-2019-129685

Published: 2019

Journal Articles

Lisocabtagene Maraleucel (liso-cel) for Treatment of Second-Line Transplant Noneligible (TNE) Relapsed/Refractory (R/R) Aggressive Non-Hodgkin Lymphoma (NHL): Initial Results from the PILOT Study

Alison R. Sehgal, MD, John Godwin, John Pribble, Lei Wang, PhD, Jerill Thorpe, BSc, Gerhard C. Hildebrandt, MD

Blood (2019) 134 (Supplement_1): 2882.

https://doi.org/10.1182/blood-2019-127658

Published: 2019

Journal Articles

Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium

Joanna S. Yi, MD, Tiffany Chambers, MPH, Kelly D Getz, Tamara P. Miller, MDMSc, Evanette Burrows, MPH, Marla Daves, MD, Philip J. Lupo, PhD MPH, Michael E. Scheurer, PhD MPH, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, Maria Monica J. Gramatges, MD PhD

Blood (2019) 134 (Supplement_1): 3814.

https://doi.org/10.1182/blood-2019-123992

Published: 2019

Journal Articles

A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Unreported in ALL

Mateo Mejia Saldarriaga, MD, Amir Steinberg, MD, Adam F. Binder, MD

Blood (2018) 132 (Supplement 1): 5136.

https://doi.org/10.1182/blood-2018-99-112652

Published: 2018

Journal Articles

Comparing the Liver Function of Children with Acute Lymphoblastic Leukemia (ALL) Receiving Standard or High Intensity Treatment during the Interim Maintenance I Phase of Therapy: A Study of 658 Patients

Joanna S. Yi, MD, Tiffany Simone Chambers, BS, Kelly D Getz, PhD, Michael Scheurer, MPH, PhD, Philip J Lupo, PhD, Evanette Burrows, MPH, Marla Daves, MD, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, M. Monica Gramatges, MD PhD

Blood (2018) 132 (Supplement 1): 1383.

https://doi.org/10.1182/blood-2018-99-115691

Published: 2018

Journal Articles

Phase 2 Trial of Smoothened (SMO) Inhibitor PF-04449913 (PF-04) in Refractory Myelodysplastic Syndromes (MDS)

Jeffrey E. Lancet, MD, Rami S Komrokji, MD, Kendra L. Sweet, MD, Vu H. Duong, MD, Kathy L McGraw, PhD, Ling Zhang, MD, Lisa Ann Nardelli, BS, Zhenjun Ma, PhD, Richard R Reich, PhD, Eric Padron, MD, Alan F List, MD

Blood (2016) 128 (22): 3174.

https://doi.org/10.1182/blood.V128.22.3174.3174

Published: 2016

Journal Articles

Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)

Mark W. Drummond, PhD MD, Daniel J. DeAngelo, MD PhD, Michael W. Deininger, MD PhD, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Albert Thomas Quiery, MD, Elizabeth O Hexner, MD, Hongliang Shi, MS, Terri Alvarez-Diez, PhD, Erica K. Evans, PhD, Mary Ellen Healy, MS, Beni B. Wolf, MD PhD, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 477.

https://doi.org/10.1182/blood.V128.22.477.477

Published: 2016

Journal Articles

Effect of Renal and Hepatic Function on Pomalidomide Dose in Patients with Relapsed/Refractory Multiple Myeloma

Adriana C Rossi, MD, Ekta Aneja, MBBS, Angelique Boyer, David Jayabalan, BSMS, MSc, Tomer M Mark, MD MSc, Roger Pearse, MD PhD, Karen Pekle, NP, Arthur Perry, PA, Morton Coleman, MD, Ruben Niesvizky, MD

Blood (2014) 124 (21): 4754.

https://doi.org/10.1182/blood.V124.21.4754.4754

Published: 2014

Journal Articles

Phenotypic Characterization the Townes Sickle Mice

Julia Nguyen, BS, Fuad Abdulla, Chunsheng Chen, Phong Nguyen, Minh Nguyen, Benjamin Tittle, Gerard O'Sullivan, MVB, MSc, PhD MACVSc, John D. Belcher, PhD, Gregory M. Vercellotti, MD

Blood (2014) 124 (21): 4916.

https://doi.org/10.1182/blood.V124.21.4916.4916

Published: 2014

Journal Articles

PKC412 (Midostaurin) Is Safe and Highly Effective in Systemic Mastocytosis Patients: The Bologna Experience

Cristina Papayannidis, Mariachiara Abbenante, Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, Federica Frabetti, Emanuela Ottaviani, Anna Ferrari, Viviana Guadagnuolo, Chiara Sartor, Simona Soverini, Caterina De Benedittis, Carmen Baldazzi, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli

Blood (2012) 120 (21): 1749.

https://doi.org/10.1182/blood.V120.21.1749.1749

Published: 2012

Journal Articles

Hepatitis E Virus: A Novel Opportunistic Pathogen in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Jurjen Versluis, MD, Suzan D Pas, Erik Agteresch, MD, Rob A de Man, MD PhD, Albert Osterhaus, DVM, PhD, Annemiek A van der Eijk, MD PhD, Jan Cornelissen, MD PhD

Blood (2012) 120 (21): 4137.

https://doi.org/10.1182/blood.V120.21.4137.4137

Published: 2012

Journal Articles

A Phase I Study of the Vascular Disrupting Combretastatin, OXi4503, in Patients with Relapsed and Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Christopher R Cogle, MD, Andres Gonzalez, BS, Leslie Pettiford, RN, Amy Meacham, MS, Elizabeth Wise, BS, Maxim Norkin, MD, PhD, David Chaplin, PhD, Jai Balkissoon, MD, Jack W Hsu, MD, Randy A Brown, MD, John W Hiemenz, MD, John R Wingard, MD

Blood (2012) 120 (21): 4335.

https://doi.org/10.1182/blood.V120.21.4335.4335

Published: 2012

Journal Articles

Antithrombotic Therapy in Non-Neoplastic Chronic Portal Venous Thrombosis in Cirrhosis: Recanalization and Liver Function Evaluation,

Leyre Bento, Ana Rodriguez Huerta, Cristina Pascual, Gloria Pérez Rus, Vega Catalina, Ismael Yepes, Ana María Pérez-Corral, Javier Anguita, Mi Kwon, Jose Luis Diez Martin

Blood (2011) 118 (21): 3358.

https://doi.org/10.1182/blood.V118.21.3358.3358

Published: 2011

Journal Articles

Inotuzumab Ozogamycin (I0), a CD22 Monoclonal Antibody Conjugated to Calecheamicin, Is Active in Refractory-Relapse Acute Lymphocytic Leukemia (R-R ALL)

Susan o'Brien, Deborah A. Thomas, MD, Maro Ohanian, M.D., Jeffrey L. Jorgensen, MD, PhD, Partow Kebriaei, MD, Elias Jabbour, Michael E. Rytting, MD, Sergernne York, RN, Farhad Ravandi, MD, Monica Kwari, BSN, Stefan Faderl, MD, Mary Beth Rios, RN, Jorge E. Cortes, Luis Fayad, MD, Robert Tarnai, MT, Sa A. Wang, MD, Richard Champlin, MD, Anjali S. Advani, MD, Hagop M. Kantarjian

Blood (2011) 118 (21): 875.

https://doi.org/10.1182/blood.V118.21.875.875

Published: 2011

Journal Articles

Transfused Myelodysplastic Syndromes (MDS) Patients Have Severe Iron Overload and Relevant Improvements in Iron Burden and Liver Function with Deferasirox Treatment: Results From a Pooled Analysis

Norbert Gattermann, MD, Peter L. Greenberg, MD, Akio Urabe, MD, PhD, Dany Habr, MD, Euloge E. Kpamegan, PhD, John B. Porter, MD

Blood (2011) 118 (21): 5019.

https://doi.org/10.1182/blood.V118.21.5019.5019

Published: 2011

Journal Articles

Effects of Hepatic Function on the Pharmacokinetics and Safety of Panobinostat in Patients with Advanced Cancer: A Phase I Study

Dagmar Hess, MD, Nicole Hagner, MD, Sally Clive, MD, Hans Gelderblom, MD, PhD, Eva Rossmann, MD, PhD, Neeraj Agarwal, MD, Maria Grazia Porro, PhD, Thomas Hengelage, PhD, Annie St-Pierre, PhD, Lucien Gazi, PhD, Jason Li, PhD, Margaret M. Woo, PharmD, Sunil Sharma, MD

Blood (2011) 118 (21): 5007.

https://doi.org/10.1182/blood.V118.21.5007.5007

Published: 2011

Journal Articles

The Phenotype of Endothelium in Children with ALL Might Be a Predictor of the Outcome – a Pilot Study

Adrian Doroszko, Ewa Niedzielska, Julita Porwolik, Ewa Szahidewicz- Krupska, Alicja Chybicka, Andrzej Szuba

Blood (2011) 118 (21): 5314.

https://doi.org/10.1182/blood.V118.21.5314.5314

Published: 2011

Journal Articles

Favourable Outcome of B-Cell Non Hodgkin Lymphomas Associated with Hepatitis C Virus - ANRS HC13 LYMPHO-C Observational Study

Caroline Besson, Danielle Canioni, MD, Catherine Settegrana, Henda Driss, Laurent Alric, Cyrille Feray, Felipe Suarez, Florence N Guyen Khac, Helene Merle-Beral, Patrice Cacoub, Frederic Davi, Olivier Hermine, MD, PhD

Blood (2010) 116 (21): 3116.

https://doi.org/10.1182/blood.V116.21.3116.3116

Published: 2010

Journal Articles

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Chenthil Rathnasabapathy, MD, Kathleen West, Ph.D, Gerald Fetterly, Ph.D, Minocher Battiwalla, MD, Shannon L Smiley, MD, Theresa Hahn, PhD, Karen Brown, NP, Karen Arnold, NP, Margaret Syta, NP, Pamela Paplham, NP, Joann Liu, NP, Philip L. McCarthy, MD

Blood (2009) 114 (22): 2276.

https://doi.org/10.1182/blood.V114.22.2276.2276

Published: 2009

Journal Articles

Aggressive Systemic Mastocytosis Is Associated with a High Kit D816V Allele Burden in Peripheral Blood.

Philipp Erben, MD, Georg Bolz, MD, Juliana Popa, MD, Georgia Metzgeroth, MD, Martin C Müller, MD, Darko Gosenca, PhD, Thomas Ernst, MD, Wolf-Karsten Hofmann, MD, Andreas Hochhaus, MD, Andreas Reiter, MD

Blood (2009) 114 (22): 2899.

https://doi.org/10.1182/blood.V114.22.2899.2899

Published: 2009

NARROW

A Phase 1a/b Dose Escalation Study of Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS

Lisocabtagene Maraleucel (liso-cel) for Treatment of Second-Line Transplant Noneligible (TNE) Relapsed/Refractory (R/R) Aggressive Non-Hodgkin Lymphoma (NHL): Initial Results from the PILOT Study

Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium

A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Unreported in ALL

Comparing the Liver Function of Children with Acute Lymphoblastic Leukemia (ALL) Receiving Standard or High Intensity Treatment during the Interim Maintenance I Phase of Therapy: A Study of 658 Patients

Phase 2 Trial of Smoothened (SMO) Inhibitor PF-04449913 (PF-04) in Refractory Myelodysplastic Syndromes (MDS)

Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)

Effect of Renal and Hepatic Function on Pomalidomide Dose in Patients with Relapsed/Refractory Multiple Myeloma

Phenotypic Characterization the Townes Sickle Mice

PKC412 (Midostaurin) Is Safe and Highly Effective in Systemic Mastocytosis Patients: The Bologna Experience

Hepatitis E Virus: A Novel Opportunistic Pathogen in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

A Phase I Study of the Vascular Disrupting Combretastatin, OXi4503, in Patients with Relapsed and Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Antithrombotic Therapy in Non-Neoplastic Chronic Portal Venous Thrombosis in Cirrhosis: Recanalization and Liver Function Evaluation,

Inotuzumab Ozogamycin (I0), a CD22 Monoclonal Antibody Conjugated to Calecheamicin, Is Active in Refractory-Relapse Acute Lymphocytic Leukemia (R-R ALL)

Transfused Myelodysplastic Syndromes (MDS) Patients Have Severe Iron Overload and Relevant Improvements in Iron Burden and Liver Function with Deferasirox Treatment: Results From a Pooled Analysis

Effects of Hepatic Function on the Pharmacokinetics and Safety of Panobinostat in Patients with Advanced Cancer: A Phase I Study

The Phenotype of Endothelium in Children with ALL Might Be a Predictor of the Outcome – a Pilot Study

Favourable Outcome of B-Cell Non Hodgkin Lymphomas Associated with Hepatitis C Virus - ANRS HC13 LYMPHO-C Observational Study

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Aggressive Systemic Mastocytosis Is Associated with a High Kit D816V Allele Burden in Peripheral Blood.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only